Matches in Wikidata for { <http://www.wikidata.org/entity/Q64046612> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- Q64046612 description "clinical trial" @default.
- Q64046612 description "ensayu clínicu" @default.
- Q64046612 description "klinisch onderzoek" @default.
- Q64046612 description "клінічне випробування" @default.
- Q64046612 name "A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis" @default.
- Q64046612 type Item @default.
- Q64046612 label "A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis" @default.
- Q64046612 prefLabel "A Study of the Efficacy and Safety of Ocrelizumab in Patients With Relapsing-Remitting Multiple Sclerosis" @default.
- Q64046612 P1050 Q64046612-5D668D8D-11B3-4296-A421-26D63F893FE0 @default.
- Q64046612 P1050 Q64046612-EF231B8A-B7C0-4B1E-BB6F-4EAF9AE29ADD @default.
- Q64046612 P1132 Q64046612-64D166BF-7CCA-4248-8E62-496BB0E46CF9 @default.
- Q64046612 P1476 Q64046612-8E708D70-4899-4E55-BDDB-7FEE8C7BCF78 @default.
- Q64046612 P17 Q64046612-05E615AD-B4DE-42E8-AEE4-55EAE17D74EE @default.
- Q64046612 P17 Q64046612-0953CE4A-EBA3-41EA-8F31-95A5466C0DCD @default.
- Q64046612 P17 Q64046612-13BC7DAB-396A-4003-A08B-1E2DE50660FE @default.
- Q64046612 P17 Q64046612-1502E8CA-4896-40EE-9CE1-E19C5729D60A @default.
- Q64046612 P17 Q64046612-23C216AB-1D71-4BA0-95E2-2CCE731CD2DA @default.
- Q64046612 P17 Q64046612-243EA35C-4063-48AF-BE2C-D36F1DB08885 @default.
- Q64046612 P17 Q64046612-575D2CD5-A712-44E5-B165-4188E1770B6A @default.
- Q64046612 P17 Q64046612-6A505E91-89F3-4700-A6EF-7420AAA1AD95 @default.
- Q64046612 P17 Q64046612-72575499-AB67-4610-AE8C-12B50A344465 @default.
- Q64046612 P17 Q64046612-7522607C-1CA8-4AFE-A0B7-AA8EB5133CFE @default.
- Q64046612 P17 Q64046612-91140050-5B88-4292-8002-1BFFF0F32E61 @default.
- Q64046612 P17 Q64046612-A11F273B-314D-41C0-A79E-E3CD2CE7F049 @default.
- Q64046612 P17 Q64046612-AAA2476A-4D33-4A94-80DC-A31BE36E520A @default.
- Q64046612 P17 Q64046612-B1F78355-9BB0-4860-B7C3-61BBB7FDDC74 @default.
- Q64046612 P17 Q64046612-DB883916-FF4D-45B2-B3CB-8962F560A687 @default.
- Q64046612 P17 Q64046612-DFFEEA0D-1407-4B54-91F2-4B1BDFC37A57 @default.
- Q64046612 P17 Q64046612-EAC7B971-A16A-4414-BF61-1003C72F2A9D @default.
- Q64046612 P17 Q64046612-F7940389-A773-4669-B647-2A2EC7C7AC28 @default.
- Q64046612 P2899 Q64046612-F973472E-198F-41AD-B63B-77B40EC9F7A9 @default.
- Q64046612 P3098 Q64046612-903E01A3-D4F5-405A-B4FE-CBB66DA88F91 @default.
- Q64046612 P31 Q64046612-29C43324-3E8F-4D7F-BB20-960FF1948CE1 @default.
- Q64046612 P4135 Q64046612-EB984034-DC67-46D3-9165-95EDED5073DC @default.
- Q64046612 P580 Q64046612-45BBF1F5-B9FA-47CE-B356-313C2E6FF892 @default.
- Q64046612 P582 Q64046612-373197AA-AAE8-43D0-96B7-EFC9E103CF8D @default.
- Q64046612 P6099 Q64046612-1911C22B-59C7-4200-A19A-D49B0EA7A028 @default.
- Q64046612 P6153 Q64046612-4C6EB4C1-6751-44A8-A791-D9F6EA47BCA2 @default.
- Q64046612 P6153 Q64046612-6509F434-C6AB-4BE0-9C74-3DF2A719F6A6 @default.
- Q64046612 P6153 Q64046612-6A691931-7400-45B3-9F1F-0B9980FA562F @default.
- Q64046612 P6153 Q64046612-AC2B99A7-6A60-46A4-93CB-D3EB62BBC894 @default.
- Q64046612 P6153 Q64046612-CA549718-9E80-46E9-BE26-08EDE53D4AD4 @default.
- Q64046612 P6153 Q64046612-D508C494-8D20-4D3A-B967-35C917B09DD3 @default.
- Q64046612 P8363 Q64046612-EA09185A-361E-4A94-BEB4-111680F3F832 @default.
- Q64046612 P1050 Q140067 @default.
- Q64046612 P1050 Q8277 @default.
- Q64046612 P1132 "+220" @default.
- Q64046612 P1476 "Phase II, Multicenter, Randomized, Parallel-Group, Partially Blinded, Placebo and Avonex Controlled Dose Finding Study to Evaluate the Efficacy As Measured by Brain MRI Lesions, and Safety of 2 Dose Regimens of Ocrelizumab in Patients With RRMS" @default.
- Q64046612 P17 Q142 @default.
- Q64046612 P17 Q145 @default.
- Q64046612 P17 Q16 @default.
- Q64046612 P17 Q183 @default.
- Q64046612 P17 Q212 @default.
- Q64046612 P17 Q214 @default.
- Q64046612 P17 Q218 @default.
- Q64046612 P17 Q219 @default.
- Q64046612 P17 Q29 @default.
- Q64046612 P17 Q30 @default.
- Q64046612 P17 Q31 @default.
- Q64046612 P17 Q33 @default.
- Q64046612 P17 Q35 @default.
- Q64046612 P17 Q38 @default.
- Q64046612 P17 Q39 @default.
- Q64046612 P17 Q403 @default.
- Q64046612 P17 Q55 @default.
- Q64046612 P17 Q96 @default.
- Q64046612 P2899 "+18" @default.
- Q64046612 P3098 "NCT00676715" @default.
- Q64046612 P31 Q30612 @default.
- Q64046612 P4135 "+55" @default.
- Q64046612 P580 "2008-07-31T00:00:00Z" @default.
- Q64046612 P582 "2012-03-09T00:00:00Z" @default.
- Q64046612 P6099 Q42824440 @default.
- Q64046612 P6153 Q2892284 @default.
- Q64046612 P6153 Q2936440 @default.
- Q64046612 P6153 Q3145237 @default.
- Q64046612 P6153 Q4117596 @default.
- Q64046612 P6153 Q4863895 @default.
- Q64046612 P6153 Q7914455 @default.
- Q64046612 P8363 Q78089383 @default.